» Articles » PMID: 32319182

Klotho Protein Contributes to Cardioprotection During Ischaemia/reperfusion Injury

Overview
Journal J Cell Mol Med
Date 2020 Apr 23
PMID 32319182
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Restoration of blood flow to ischaemic heart inflicts ischaemia/reperfusion (I/R) injury, which manifests in metabolic and morphological disorders. Klotho is a protein with antioxidative and antiapoptotic activity, and is involved in the regulation of inflammation and fibrosis. The aim of the current research was to determine the role of Klotho in the heart subjected to I/R injury, as well as to study Klotho as a potential cardioprotective agent. Human cardiomyocytes and Wistar rat hearts perfused using Langendorff method subjected to I/R have been used. Hemodynamic parameters of heart function, markers of I/R injury, and gene and protein expression of Klotho were measured. Human cardiomyocytes were also incubated in the presence of recombinant Klotho protein, and the viability of cells was measured. There was a higher expression of Klotho gene and protein synthesis in the cardiomyocytes subjected to I/R injury. The compensatory production and release of Klotho protein from cardiac tissue during I/R were also shown. The treatment of cardiomyocytes subjected to I/R with Klotho protein resulted in increased viability and metabolic activity of cells. Thus, Klotho contributes to compensatory mechanism during I/R, and could be used as a marker of injury and as a potential cardiopreventive/cardioprotective agent.

Citing Articles

Study on the Synergistic Effect of Klotho and KRAS on Reducing Ferroptosis After Myocardial Infarction by Regulating RAP1/ERK Signaling Pathway.

Cai C, Wu Y, Feng X, Ye X, Liu P, Huang X Appl Biochem Biotechnol. 2025; .

PMID: 39808407 DOI: 10.1007/s12010-024-05171-3.


Mixture of Doxycycline, ML-7 and L-NAME Restores the Pro- and Antioxidant Balance during Myocardial Infarction-In Vivo Pig Model Study.

Bil-Lula I, Kuliczkowski W, Krzywonos-Zawadzka A, Frydrychowski P, Stygar D, Halucha K Biomedicines. 2024; 12(4).

PMID: 38672140 PMC: 11047935. DOI: 10.3390/biomedicines12040784.


Gene Therapy Strategies Targeting Aging-Related Diseases.

Yu J, Li T, Zhu J Aging Dis. 2023; 14(2):398-417.

PMID: 37008065 PMC: 10017145. DOI: 10.14336/AD.2022.00725.


The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells.

Wolf L, Foller M, Feger M Front Endocrinol (Lausanne). 2023; 14:1069715.

PMID: 36967770 PMC: 10032406. DOI: 10.3389/fendo.2023.1069715.


Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury.

Gonzalez-Lafuente L, Navarro-Garcia J, Valero-Almazan A, Rodriguez-Sanchez E, Vazquez-Sanchez S, Mercado-Garcia E Int J Mol Sci. 2023; 24(2).

PMID: 36674838 PMC: 9867237. DOI: 10.3390/ijms24021322.


References
1.
Zhao Z, Vinten-Johansen J . Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res. 2006; 70(2):200-11. DOI: 10.1016/j.cardiores.2006.01.024. View

2.
Zhou X, Wang X . Klotho: a novel biomarker for cancer. J Cancer Res Clin Oncol. 2014; 141(6):961-9. DOI: 10.1007/s00432-014-1788-y. View

3.
Semba R, Cappola A, Sun K, Bandinelli S, Dalal M, Crasto C . Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc. 2011; 59(9):1596-601. PMC: 3486641. DOI: 10.1111/j.1532-5415.2011.03558.x. View

4.
Sugiura H, Yoshida T, Tsuchiya K, Mitobe M, Nishimura S, Shirota S . Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant. 2005; 20(12):2636-45. DOI: 10.1093/ndt/gfi165. View

5.
Hu M, Shi M, Gillings N, Flores B, Takahashi M, Kuro-O M . Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017; 91(5):1104-1114. PMC: 5592833. DOI: 10.1016/j.kint.2016.10.034. View